These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Collagen Membranes Adsorb the Transforming Growth Factor-β Receptor I Kinase-Dependent Activity of Enamel Matrix Derivative. Stähli A; Miron RJ; Bosshardt DD; Sculean A; Gruber R J Periodontol; 2016 May; 87(5):583-90. PubMed ID: 26777762 [TBL] [Abstract][Full Text] [Related]
13. TGF-β Activity Related to the Use of Collagen Membranes: In Vitro Bioassays. Panahipour L; Kargarpour Z; Luza B; Lee JS; Gruber R Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927851 [TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro. Pan R; Zhang Y; Zang B; Tan L; Jin M J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091 [TBL] [Abstract][Full Text] [Related]
15. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells. Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118 [TBL] [Abstract][Full Text] [Related]
16. p38 MAP kinase mediates transforming-growth factor-β1-induced upregulation of matrix metalloproteinase-9 but not -2 in human brain pericytes. Takahashi Y; Maki T; Liang AC; Itoh K; Lok J; Osumi N; Arai K Brain Res; 2014 Dec; 1593():1-8. PubMed ID: 25451097 [TBL] [Abstract][Full Text] [Related]
17. Antiseptic solutions modulate the paracrine-like activity of bone chips: differential impact of chlorhexidine and sodium hypochlorite. Sawada K; Caballé-Serrano J; Bosshardt DD; Schaller B; Miron RJ; Buser D; Gruber R J Clin Periodontol; 2015 Sep; 42(9):883-891. PubMed ID: 26284317 [TBL] [Abstract][Full Text] [Related]
18. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors. Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque. Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292 [TBL] [Abstract][Full Text] [Related]
20. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression. Koo BH; Kim Y; Je Cho Y; Kim DS Eur J Pharmacol; 2015 Oct; 764():413-423. PubMed ID: 26187313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]